News > Latest News

Walk News | Sponsor & Foundation News | News in the Parkinson's Disease Community

Findings on Using Azilect (Rasagiline) as an Add-On Therapy


A Phase 3 Japanese trial has found that adding Azilect (rasagiline) to levodopa is safe, and over the course of a year improved motor function in those with Parkinson’s disease with off periods.  The Journal of Neural Transmission published the results of the study Long-Term Safety and Efficacy of Adjunctive Rasagiline in Levodopa-Treated Japanese Patients with Parkinson’s Disease

Read More:
https://parkinsonsnewstoday.com/2019/01/16/add-on-azilect-safe-effective-in-levodopa-treated-japanese-patients-with-parkinsons-phase-3-trial-shows/